DUCENTIS BIOTHERAPEUTICS LTD. - 10 TEMPLE BACK
Company Profile | Company Filings |
Overview
DUCENTIS BIOTHERAPEUTICS LTD. is a Private Limited Company from 10 TEMPLE BACK UNITED KINGDOM and has the status: Active.
DUCENTIS BIOTHERAPEUTICS LTD. was incorporated 9 years ago on 12/11/2014 and has the registered number: 09307415. The accounts status is TOTAL EXEMPTION FULL and accounts are next due on 30/09/2024.
DUCENTIS BIOTHERAPEUTICS LTD. was incorporated 9 years ago on 12/11/2014 and has the registered number: 09307415. The accounts status is TOTAL EXEMPTION FULL and accounts are next due on 30/09/2024.
DUCENTIS BIOTHERAPEUTICS LTD. - 10 TEMPLE BACK
This company is listed in the following categories:
72110 - Research and experimental development on biotechnology
72110 - Research and experimental development on biotechnology
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
31 / 12 | 31/10/2022 | 30/09/2024 |
Registered Office
SUITE 2 FIRST FLOOR
10 TEMPLE BACK
BRISTOL
BS1 6FL
UNITED KINGDOM
This Company Originates in : United Kingdom
Previous trading names include:
TRIPOS BIOPHARMA LTD. (until 06/07/2015)
TRIPOS BIOPHARMA LTD. (until 06/07/2015)
DUCENTIS BIOTHERAPEUTICS LTD. (until 08/05/2015)
DEUCENTIS LIMITED (until 17/11/2014)
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
24/02/2023 | 09/03/2024 |
Map
UNITED KINGDOM
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
MS JESSICA LYNN ROBISON | Aug 1982 | American | Director | 2023-12-06 | CURRENT |
MR MATTHEW MOORE | Oct 1972 | American | Director | 2022-09-09 | CURRENT |
MR MASARU MATSUDA | Mar 1970 | American | Director | 2023-12-06 | CURRENT |
MR PATRICK BURNETT | May 1971 | American | Director | 2022-09-09 | CURRENT |
MR ANDREA GIACOMO MICA | Jan 1968 | Italian | Director | 2019-06-12 UNTIL 2022-09-09 | RESIGNED |
MR PHILIPPE LENOBLE | Nov 1971 | Belgian | Director | 2019-06-12 UNTIL 2022-09-09 | RESIGNED |
DR PHILIP HUXLEY | Nov 1956 | British | Director | 2014-11-12 UNTIL 2022-09-09 | RESIGNED |
DR DAVID MARK ANTHONY HOLBROOK | May 1960 | British | Director | 2019-06-12 UNTIL 2021-04-28 | RESIGNED |
MR SCOTT BURROWS | Mar 1977 | American | Director | 2022-09-09 UNTIL 2023-08-31 | RESIGNED |
PROFESSOR DAVID JOHN BLACKBOURN | Oct 1964 | British | Director | 2015-07-09 UNTIL 2022-09-09 | RESIGNED |
DR REBECCA ASHFIELD | Jan 1967 | United Kingdom | Director | 2015-07-09 UNTIL 2022-09-09 | RESIGNED |
MR TOBY MORRIS | Secretary | 2014-11-12 UNTIL 2015-05-01 | RESIGNED | ||
DR PHILIP HUXLEY | Secretary | 2015-05-02 UNTIL 2022-09-09 | RESIGNED | ||
MRS CLARE ELIZABETH TERLOUW | Dec 1973 | British,Canadian | Director | 2021-06-10 UNTIL 2022-09-09 | RESIGNED |
DR ALAN PAUL WATT | Sep 1963 | British | Director | 2021-08-06 UNTIL 2022-09-09 | RESIGNED |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Arcutis Biotherapeutics, Inc. | 2022-09-09 | Wilmington Delaware |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
|
Lifearc | 2019-08-06 - 2022-09-09 | London | Ownership of shares 25 to 50 percent | |
Dr David Mark Anthony Holbrook | 2019-06-14 - 2021-04-28 | 5/1960 | Oxford |
Ownership of shares 25 to 50 percent as firm Voting rights 25 to 50 percent as firm |
Dr Philip Huxley | 2016-04-06 - 2022-09-09 | 11/1956 | Oxford | Significant influence or control |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
DUCENTIS_BIOTHERAPEUTICS_ - Accounts | 2023-08-01 | 31-10-2022 | £26,990 Cash £-752,424 equity |
DUCENTIS_BIOTHERAPEUTICS_ - Accounts | 2022-02-04 | 31-10-2021 | £624,323 Cash £-657,424 equity |
DUCENTIS_BIOTHERAPEUTICS_ - Accounts | 2021-03-06 | 30-11-2020 | £559,027 Cash £745,535 equity |
DUCENTIS_BIOTHERAPEUTICS_ - Accounts | 2020-06-13 | 30-11-2019 | £1,760,714 Cash £1,632,632 equity |
Accounts filed on 30-11-2018 | 2019-02-07 | 30-11-2018 | £30,848 Cash £15,291 equity |
Accounts filed on 30-11-2017 | 2018-06-26 | 30-11-2017 | £387,952 Cash £407,572 equity |
Accounts filed on 30-11-2016 | 2017-04-26 | 30-11-2016 | £5,725 Cash £4,240 equity |